MedTrace Logo

Animal Assisted Mindfulness Intervention (AAMI) for Patients With Acquired Brain Injury

NCT03729908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-03-04

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of an animal assisted mindfulness intervention (AAMI) on patients with acquired brain injuries on their global severity of psychological distress.

In addition, the effects on the patients' symptoms of depression, anxiety, perceived stress, mood, coping and mindfulness/self-compassion will be assessed.

The study experimental condition consists of 6 weeks of intervention, containing 6 different modules. In every session, an animal will be present.

In the control condition, the same program and same exercises will be used without the presence of or reference to animals. Sessions take place two times a week for 6 weeks (leading up to a total of 12 experimental/control sessions), each lasting for about 60 minutes.

24 participants are planned to be included, 12 patients in each group.

Conditions

  • Acquired Brain Injury

Interventions

BEHAVIORAL

Animal assisted mindfulness based intervention

A mindfulness based intervention in the presence of an animal

BEHAVIORAL

Anti-stress program

A mindfulness based intervention with no reference to animals

Sponsors & Collaborators

  • Rehab Basel

    collaborator OTHER

  • University of Basel

    collaborator OTHER

  • University of Bern

    collaborator OTHER

  • Swiss Tropical & Public Health Institute

    lead OTHER

Principal Investigators

  • Karin Hediger · University of Basel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-09-12
Completion
2019-09-12

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03729908 on ClinicalTrials.gov